• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-200b在结肠癌萌芽细胞中表达下调。

MicroRNA-200b is downregulated in colon cancer budding cells.

作者信息

Knudsen Kirsten Nguyen, Lindebjerg Jan, Nielsen Boye Schnack, Hansen Torben Frøstrup, Sørensen Flemming Brandt

机构信息

Danish Colorectal Cancer Center South, Vejle Hospital, Part of Lillebaelt Hospital, Kabbeltoft 25, Vejle, Denmark.

Department of Clinical Pathology, Vejle Hospital, Part of Lillebaelt Hospital, Kabbeltoft 25, Vejle, Denmark.

出版信息

PLoS One. 2017 May 26;12(5):e0178564. doi: 10.1371/journal.pone.0178564. eCollection 2017.

DOI:10.1371/journal.pone.0178564
PMID:28552992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5446202/
Abstract

BACKGROUND

The microRNA-200 (miR-200) family acts as a major suppressor of epithelial-mesenchymal transition (EMT). Impaired miR-200 expression may lead to EMT initiation and eventually cancer dissemination. The presence of tumor budding cells (TBC) is associated with metastasis and poor prognosis, and molecular similarities to EMT indicate that these cells may reflect ongoing EMT. The aim of this study was to investigate the expression of miR-200b in budding cells of colon cancer and the relationship with the EMT-markers E-cadherin, β-catenin and laminin-5γ2.

MATERIAL & METHODS: MiR-200b was investigated by in situ hybridization in 58 cases of stage II (n = 36) and III colon (n = 22) cancers with tumor budding. Expression of E-cadherin, β-catenin and laminin-5γ2 was examined by immunohistochemistry. A multiplex fluorescence assay combining miR-200b with cytokeratin and laminin-5γ2 was employed on a subset of 16 samples.

RESULTS

MiR-200b was downregulated in the TBC at the invasive front of 41 out of 58 (71%) cases. The decline was present in both mismatch satellite stable and instable adenocarcinomas. The majority of cases also showed loss of membranous E-cadherin and increased nuclear β-catenin in the TBC, while laminin-5γ2 expression was upregulated at the invasive front and in the tumor buds of approximately half the adenocarcinomas. However, the miR-200b decline was not statistically associated with the expression of any of the EMT-markers. The miR-200b decline was also documented by multiplex fluorescence. Fourteen out of fifteen cases showed a decrease in miR-200b expression in the majority of the TBC, but no obvious relationship between miR-200b and laminin-5γ2 expression was observed. Conclusion: The findings support the assumption of a miR-200b related downregulation in colon cancer budding cells. Whether miR-200b expression may be of clinical significance awaits further studies.

摘要

背景

微小RNA - 200(miR - 200)家族是上皮 - 间质转化(EMT)的主要抑制因子。miR - 200表达受损可能导致EMT启动并最终引发癌症扩散。肿瘤芽生细胞(TBC)的存在与转移及不良预后相关,且其与EMT的分子相似性表明这些细胞可能反映了正在进行的EMT过程。本研究旨在探讨miR - 200b在结肠癌芽生细胞中的表达及其与EMT标志物E - 钙黏蛋白、β - 连环蛋白和层粘连蛋白 - 5γ2的关系。

材料与方法

采用原位杂交技术对58例伴有肿瘤芽生的II期(n = 36)和III期结肠癌(n = 22)病例进行miR - 200b检测。通过免疫组织化学检测E - 钙黏蛋白、β - 连环蛋白和层粘连蛋白 - 5γ2的表达。对16个样本的子集采用将miR - 200b与细胞角蛋白和层粘连蛋白 - 5γ2相结合的多重荧光检测法。

结果

在58例病例中的41例(71%)的侵袭前沿TBC中,miR - 200b表达下调。这种下调在错配卫星稳定型和不稳定型腺癌中均存在。大多数病例的TBC还表现为膜性E - 钙黏蛋白缺失和核内β - 连环蛋白增加,而在大约一半的腺癌中,层粘连蛋白 - 5γ2在侵袭前沿和肿瘤芽中表达上调。然而,miR - 200b的下调与任何EMT标志物的表达均无统计学关联。多重荧光检测也证实了miR - 200b的下调。15例病例中的14例在大多数TBC中miR - 200b表达降低,但未观察到miR - 200b与层粘连蛋白 - 5γ2表达之间存在明显关系。结论:这些发现支持结肠癌芽生细胞中存在与miR - 200b相关的下调这一假设。miR - 200b表达是否具有临床意义有待进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/f68c84b3b47a/pone.0178564.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/791bfec451d7/pone.0178564.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/97bd6c149ae2/pone.0178564.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/f68c84b3b47a/pone.0178564.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/791bfec451d7/pone.0178564.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/97bd6c149ae2/pone.0178564.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4590/5446202/f68c84b3b47a/pone.0178564.g003.jpg

相似文献

1
MicroRNA-200b is downregulated in colon cancer budding cells.微小RNA-200b在结肠癌萌芽细胞中表达下调。
PLoS One. 2017 May 26;12(5):e0178564. doi: 10.1371/journal.pone.0178564. eCollection 2017.
2
miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy.利用共聚焦玻片扫描显微镜分析出芽结肠癌细胞中的 miR-21 表达。
Clin Exp Metastasis. 2018 Dec;35(8):819-830. doi: 10.1007/s10585-018-9945-3. Epub 2018 Oct 25.
3
53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.在乳腺癌中,53BP1通过微小RNA-200b/429下调ZEB1来抑制上皮-间质转化。
Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14.
4
Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.下调的 microRNA-200a 通过靶向胃腺癌中的 E-钙黏蛋白抑制剂 ZEB1/ZEB2,通过 wnt/β-连环蛋白通路促进 EMT 和肿瘤生长。
Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.
5
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.微小RNA-200b-3p和微小RNA-200b-5p对三阴性乳腺癌上皮-间质转化抑制的双重调控
Oncotarget. 2015 Jun 30;6(18):16638-52. doi: 10.18632/oncotarget.3184.
6
MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.MicroRNA-200b 通过直接靶向胃癌中的 ZEB2 调节细胞增殖、侵袭和迁移。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.
7
Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.异常表达的 microRNAs 参与 HT-29 细胞系的上皮-间充质转化。
Cell Biol Int. 2013 Jul;37(7):669-74. doi: 10.1002/cbin.10087. Epub 2013 May 20.
8
Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.具有特征性肿瘤芽生和错配修复蛋白状态的II期结直肠癌患者队列中的上皮-间质转化(EMT)蛋白表达
Int J Surg Pathol. 2011 Dec;19(6):751-60. doi: 10.1177/1066896911414566. Epub 2011 Jul 26.
9
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.miR-200b 和 miR-15b 通过靶向 BMI1 调节人舌癌细胞中的化疗诱导上皮-间充质转化。
Oncogene. 2012 Jan 26;31(4):432-45. doi: 10.1038/onc.2011.263. Epub 2011 Jul 4.
10
microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.微小RNA miR-200b通过靶向锌指E盒结合蛋白1(ZEB1)、锌指E盒结合蛋白2(ZEB2)和 Kruppel样因子4(KLF4)来影响子宫内膜异位症细胞的增殖、侵袭能力和干性。
Reprod Biomed Online. 2016 Apr;32(4):434-45. doi: 10.1016/j.rbmo.2015.12.013. Epub 2016 Jan 15.

引用本文的文献

1
, and Are Downregulated in Colorectal Carcinoma with Serosal Invasion.在伴有浆膜侵犯的结直肠癌中,[具体内容缺失]和[具体内容缺失]表达下调。
Biomedicines. 2022 Sep 1;10(9):2149. doi: 10.3390/biomedicines10092149.
2
Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.结直肠癌中的肿瘤芽和分化不良的簇——部分上皮-间充质转化的不同表现。
J Pathol. 2022 Nov;258(3):278-288. doi: 10.1002/path.5998. Epub 2022 Sep 5.
3
Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer-A Systematic Review and Bioinformatics Analysis.

本文引用的文献

1
Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.结直肠癌浸润前沿的肿瘤芽生可能与上皮-间质转化无关。
Hum Pathol. 2017 Feb;60:151-159. doi: 10.1016/j.humpath.2016.10.007. Epub 2016 Nov 9.
2
Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.结直肠癌中肿瘤芽生影响的系统评价和荟萃分析
Br J Cancer. 2016 Sep 27;115(7):831-40. doi: 10.1038/bjc.2016.274. Epub 2016 Sep 6.
3
Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma.
长链非编码RNA作为结直肠癌中EMT相关转录因子的潜在调节因子——系统综述与生物信息学分析
Cancers (Basel). 2022 May 3;14(9):2280. doi: 10.3390/cancers14092280.
4
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.微小RNA的miR-200家族:上皮-间质转化的精细调节因子及循环肿瘤生物标志物
Cancers (Basel). 2021 Nov 23;13(23):5874. doi: 10.3390/cancers13235874.
5
Epithelial-Mesenchymal Transition in Colorectal Carcinoma: Comparison Between Primary Tumor, Lymph Node and Liver Metastases.结直肠癌中的上皮-间质转化:原发肿瘤、淋巴结和肝转移灶之间的比较
Front Oncol. 2021 May 11;11:662806. doi: 10.3389/fonc.2021.662806. eCollection 2021.
6
Automated Five-Color Multiplex Co-detection of MicroRNA and Protein Expression in Fixed Tissue Specimens.自动化固定组织标本中 microRNA 和蛋白质表达的五色多重共检测。
Methods Mol Biol. 2020;2148:257-276. doi: 10.1007/978-1-0716-0623-0_17.
7
RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer.RAS、细胞可塑性与结直肠癌中的肿瘤芽生
Front Oncol. 2019 Nov 19;9:1255. doi: 10.3389/fonc.2019.01255. eCollection 2019.
8
Epithelial-Mesenchymal Transition-Related MicroRNAs and Their Target Genes in Colorectal Cancerogenesis.结直肠癌发生过程中上皮-间质转化相关的微小RNA及其靶基因
J Clin Med. 2019 Oct 3;8(10):1603. doi: 10.3390/jcm8101603.
9
Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario.胰腺癌联合免疫表型、分子和形态学分析中出现的临床情况:好的、坏的和糟糕的情况。
Cancers (Basel). 2019 Jul 10;11(7):968. doi: 10.3390/cancers11070968.
10
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.胰腺癌的肿瘤微环境:免疫景观由分子和组织病理学特征决定。
Br J Cancer. 2019 Jul;121(1):5-14. doi: 10.1038/s41416-019-0479-5. Epub 2019 May 21.
miR-320a表达降低促进舌鳞状细胞癌中肿瘤芽生细胞的侵袭和转移。
Oncotarget. 2016 Oct 4;7(40):65744-65757. doi: 10.18632/oncotarget.11612.
4
Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.锌指E盒结合同源框蛋白1的异质性表达通过调控上皮-间质转化过程中的miR-200c在转移中起关键作用。
Int J Oncol. 2016 Sep;49(3):1057-67. doi: 10.3892/ijo.2016.3583. Epub 2016 Jun 17.
5
Tumor Budding: The Name is EMT. Partial EMT.肿瘤芽生:其本质是上皮-间质转化。部分上皮-间质转化。
J Clin Med. 2016 Apr 29;5(5):51. doi: 10.3390/jcm5050051.
6
Tumour budding in colorectal cancer: what do we know and what can we do?结直肠癌中的肿瘤芽生:我们知道什么以及我们能做什么?
Virchows Arch. 2016 Apr;468(4):397-408. doi: 10.1007/s00428-015-1886-5. Epub 2015 Nov 27.
7
Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.肿瘤芽生的分子谱分析表明,TGFβ 介导的上皮-间充质转化是口腔鳞状细胞癌的治疗靶点。
J Pathol. 2015 Aug;236(4):505-16. doi: 10.1002/path.4550. Epub 2015 Jun 1.
8
Molecular and pathogenetic aspects of tumor budding in colorectal cancer.结直肠癌中肿瘤芽生的分子和发病机制方面。
Front Med (Lausanne). 2015 Mar 10;2:11. doi: 10.3389/fmed.2015.00011. eCollection 2015.
9
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.结直肠癌中的肿瘤芽生再探讨:一项多中心观察者间研究的结果
Virchows Arch. 2015 May;466(5):485-93. doi: 10.1007/s00428-015-1740-9. Epub 2015 Feb 21.
10
MiR-200, a new star miRNA in human cancer.miR-200,人类癌症中一个新的明星 miRNA。
Cancer Lett. 2014 Mar 28;344(2):166-73. doi: 10.1016/j.canlet.2013.11.004. Epub 2013 Nov 19.